Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29951221 | 1.00 | ALDH1A1 (0.60) | ALDH1A1TSHRHPGDSMN1; SMN2HTT | |
| SCHEMBL11002560 | 0.83 | TSHR (0.50) | ALDH1A1TSHRHPGDSMN1; SMN2HTT | |
| SCHEMBL28248465 | 0.82 | ALDH1A1 (0.63) | ALDH1A1TSHRHPGDSMN1; SMN2HTT | |
| SCHEMBL27554222 | 0.82 | ALDH1A1 (0.58) | ALDH1A1TSHRHPGDSMN1; SMN2HTT | |
| SCHEMBL28003371 | 0.82 | ALDH1A1 (0.58) | ALDH1A1TSHRHPGDSMN1; SMN2HTT | |
| SCHEMBL10885936 | 0.82 | ALDH1A1 (0.58) | ALDH1A1TSHRHPGDSMN1; SMN2HTT | |
| SCHEMBL1802351 | 0.82 | ALDH1A1 (0.58) | ALDH1A1TSHRHPGDSMN1; SMN2HTT | |
| SCHEMBL30367918 | 0.82 | ALDH1A1 (0.58) | ALDH1A1TSHRHPGDSMN1; SMN2HTT | |
| SCHEMBL1135905 | 0.82 | ALDH1A1 (0.58) | ALDH1A1TSHRHPGDSMN1; SMN2HTT | |
| SCHEMBL876143 | 0.82 | ALDH1A1 (0.58) | ALDH1A1TSHRHPGDSMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 256 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1829872-B1 | PROCESSES FOR PRODUCTION OF INDOLE COMPOUNDS | NISSAN CHEMICAL IND LTD (JP) | 2015-07-29 | — | — | EP | claimed |
| CN-103275169-A | Furostanol saponins and synthesis method thereof | OCEAN UNIV CHINA | 2013-09-04 | — | — | CN | claimed |
| CN-103265608-A | Solanidine type glycoalkaloid and convergent synthesis method thereof | OCEAN UNIV CHINA | 2013-08-28 | — | — | CN | claimed |
| CN-103193858-A | Synthetic method of spirosolane glycoalkaloids | OCEAN UNIV CHINA | 2013-07-10 | — | — | CN | claimed |
| CN-101468964-B | Processes for producing indole compound | NISSAN CHEMICAL IND LTD | 2011-05-11 | — | — | CN | claimed |
| US-20100197938-A1 | Process for producing indole compoud | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-08-05 | — | — | US | claimed |
| CN-100577659-C | Processes for producing indole compound | NISSAN CHEMICAL IND LTD | 2010-01-06 | — | — | CN | claimed |
| CN-101468964-A | Processes for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2009-07-01 | — | — | CN | claimed |
| EP-1829872-A1 | PROCESSES FOR PRODUCTION OF INDOLE COMPOUNDS | Nissan Chemical Industries, Ltd. (JP) | 2007-09-05 | — | — | EP | claimed |
| CN-1896075-A | Processes for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2007-01-17 | — | — | CN | claimed |
| CN-1646522-A | Process for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2005-07-27 | — | — | CN | claimed |
| EP-0489547-B1 | A process for the preparation of a 3-alkylated indole, intermediates, and a process for the preparation of a derivative thereof | ZENECA LTD (GB) | 1998-07-29 | — | — | EP | claimed |
| EP-0703825-B1 | METHOD AND APPARATUS FOR CONDUCTING AN ARRAY OF CHEMICAL REACTIONS ON A SUPPORT SURFACE | PROTOGENE LAB INC (US) | 1997-07-30 | — | — | EP | claimed |
| EP-0240659-B2 | N-substituted 3,4,5,6-tetrahydrophthalimides and their precursors | BASF AG (DE) | 1994-10-26 | — | — | EP | claimed |
| US-5280125-A | Chemical process for the preparation of 3-alkylated indole | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1994-01-18 | — | — | US | claimed |
| EP-0489547-A1 | A process for the preparation of a 3-alkylated indole, intermediates, and a process for the preparation of a derivative thereof | ZENECA LIMITED (GB) | 1992-06-10 | — | — | EP | claimed |
| EP-0362634-A2 | Basic dihydropyridines, process for their preparation and their use as intermediates | BAYER AG (DE) | 1990-04-11 | — | — | EP | claimed |
| EP-0240659-A2 | N-substituted 3,4,5,6-tetrahydrophthalimides and their precursors | BASF Aktiengesellschaft (DE) | 1987-10-14 | — | — | EP | claimed |
| US-3931225-A | Process for preparing o-nitrobenzylketones | HOFFMANN-LA ROCHE INC. (US) | 1976-01-06 | — | — | US | claimed |
| JP-4266870-A | — | — | None | — | — | JP | disclosed |
| EP-3958865-B1 | 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES | BAYER AG (DE) | 2025-12-10 | — | — | EP | disclosed |
| US-12403135-B2 | 4H-pyrrolo[3,2-c]pyridin-4-one derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 2025-09-02 | — | — | US | disclosed |
| US-20250215467-A1 | L-THREONINE TRANSALDOLASES AND USES THEREOF | UNIVERSITY OF DELAWARE (US) | 2025-07-03 | — | — | US | disclosed |
| WO-2023178318-A2 | L-THREONINE TRANSALDOLASES AND USES THEREOF | KUNJAPUR ADITYA (US) | 2023-09-21 | — | — | WO | disclosed |
| EP-3700904-B1 | 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES | BAYER AG (DE) | 2023-07-19 | — | — | EP | disclosed |
| CN-116234798-A | Sulfamate derivative compounds for the treatment or alleviation of psychotic disorders | 生物药品解决方案有限公司 | 2023-06-06 | — | — | CN | disclosed |
| US-20220378762-A1 | 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2022-12-01 | — | — | US | disclosed |
| CN-114591160-A | Method for preparing aryl acetaldehyde from aryl formaldehyde and diaryl ketone | 长沙资材科技有限公司 | 2022-06-07 | — | — | CN | disclosed |
| US-11339157-B1 | 4H-pyrrolo[3,2-c]pyridin-4-one derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 2022-05-24 | — | — | US | disclosed |
| EP-3958865-A1 | 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES | Bayer Aktiengesellschaft (DE) | 2022-03-02 | — | — | EP | disclosed |
| US-20210179578-A1 | OX1 ANTAGONISTS | HEPTARES THERAPEUTICS LTD (GB) | 2021-06-17 | — | — | US | disclosed |
| US-20210179578-A1 | OX1 ANTAGONISTS | HEPTARES THERAPEUTICS LTD (GB) | 2021-06-17 | — | — | US | disclosed |
| CN-111995577-A | Synthetic method of 4-fluoro indazole 3-carbonitrile or derivatives thereof | 上海代为化学科技有限公司 | 2020-11-27 | — | — | CN | disclosed |
| WO-2020216774-A1 | 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2020-10-29 | — | — | WO | disclosed |
| EP-3710435-A1 | OX1 ANTAGONISTS | Heptares Therapeutics Limited (GB) | 2020-09-23 | — | — | EP | disclosed |
| EP-3700904-A1 | 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES | Bayer AG (DE) | 2020-09-02 | — | — | EP | disclosed |
| CN-106507667-B | Sulfamate derivatives for the prevention or treatment of epilepsy | 比皮艾思药物研发有限公司 | 2020-01-24 | — | — | CN | disclosed |
| US-20180346484-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBVIE DEUTSCHLAND (DE) | 2018-12-06 | — | — | US | disclosed |
| EP-3307067-A1 | AMINOPYRAZINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES | Merck Sharp & Dohme Corp. (US) | 2018-04-18 | — | — | EP | disclosed |
| US-9879033-B2 | Modulators of 5-HT receptors and methods of use thereof | AbbVie Deutschland GmbH & Co. KG (DE) | 2018-01-30 | — | — | US | disclosed |
| CN-107311829-A | The synthetic method of fragrant second aldehyde compound | 凯莱英生命科学技术(天津)有限公司 | 2017-11-03 | — | — | CN | disclosed |
| US-9745280-B2 | Compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient | SNU R&DB FOUNDATION (KR) | 2017-08-29 | — | — | US | disclosed |
| EP-2571353-B1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBVIE INC (US) | 2017-08-09 | — | — | EP | disclosed |
| CN-106507667-A | For preventing or treating the sulfamate derivatives of epilepsy | 比皮艾思药物研发有限公司 | 2017-03-15 | — | — | CN | disclosed |
| EP-2788359-B1 | COMPOSITION AND METHOD FOR NEUROPEPTIDE S RECEPTOR (NPSR) ANTAGONISTS | RES TRIANGLE INST (US) | 2017-03-01 | — | — | EP | disclosed |
| WO-2016200717-A1 | AMINOPYRAZINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES | MERCK SHARP & DOHME CORP. (US) | 2016-12-15 | — | — | WO | disclosed |
| US-20160340331-A1 | NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT | SNU R&DB FOUNDATION (KR) | 2016-11-24 | — | — | US | disclosed |
| WO-2016164412-A1 | HYPOXIA-INDUCIBLE FACTOR 1 (HIF-1) INHIBITORS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2016-10-13 | — | — | WO | disclosed |
| US-20160207938-A1 | QUINAZOLINE DERIVATIVES | JANSSEN PHARMACEUTICA NV (BE) | 2016-07-21 | — | — | US | disclosed |
| CN-105481864-A | Modulators of 5-HT receptors and methods of use thereof | ABBOTT GMBH & CO KG ABBOTT LAB | 2016-04-13 | — | — | CN | disclosed |
| US-20160096851-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBVIE INC. | 2016-04-07 | — | — | US | disclosed |
| EP-2989106-A1 | FUSED HETEROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS | Beigene, Ltd. (KY) | 2016-03-02 | — | — | EP | disclosed |
| US-9273013-B2 | Quinazoline derivatives | JANSSEN PHARMACEUTICA NV (BE) | 2016-03-01 | — | — | US | disclosed |
| CN-102712643-B | Modulators of 5-HT receptors and methods of use thereof | ABBVIE (US) | 2015-12-16 | — | — | CN | disclosed |
| US-9187483-B2 | Modulators of 5-HT receptors and methods of use thereof | ABBVIE INC. (US) | 2015-11-17 | — | — | US | disclosed |
| CN-104860951-A | Modulators of 5-HT receptors and methods of use thereof | AbbVie Deutschland GmbH and Co KG | 2015-08-26 | — | — | CN | disclosed |
| EP-1829872-B1 | PROCESSES FOR PRODUCTION OF INDOLE COMPOUNDS | NISSAN CHEMICAL IND LTD (JP) | 2015-07-29 | — | — | EP | disclosed |
| CN-103265608-B | Solanidine type glycoalkaloid and convergent synthesis method thereof | OCEAN UNIV CHINA | 2015-04-22 | — | — | CN | disclosed |
| US-8969573-B2 | Compounds for the inhibition of cellular proliferation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-03-03 | — | — | US | disclosed |
| US-8969573-B2 | Compounds for the inhibition of cellular proliferation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-03-03 | — | — | US | disclosed |
| EP-2641907-B1 | Preparation of modulators of 5-HT receptors | ABBVIE INC (US) | 2015-01-28 | — | — | EP | disclosed |
| US-8933067-B2 | Pyrido and pyrimidopyrimidine derivatives as anti-profilerative agents | JANSSEN PHARMACEUTICA NV (BE) | 2015-01-13 | — | — | US | disclosed |
| WO-2014173289-A1 | FUSED HETEROCYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS | BEIGENE, LTD. (KY) | 2014-10-30 | — | — | WO | disclosed |
| US-8865704-B2 | Wnt pathway antagonists | SIENA BIOTECH S.P.A. (IT) | 2014-10-21 | — | — | US | disclosed |
| US-8865704-B2 | Wnt pathway antagonists | SIENA BIOTECH S.P.A. (IT) | 2014-10-21 | — | — | US | disclosed |
| US-8865704-B2 | Wnt pathway antagonists | SIENA BIOTECH S.P.A. (IT) | 2014-10-21 | — | — | US | disclosed |
| US-8846951-B2 | Modulators of 5-HT receptors and methods of use thereof | ABBVIE INC. (US) | 2014-09-30 | — | — | US | disclosed |
| US-8772272-B2 | Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents | JANSSEN PHARMACEUTICA NV (BG) | 2014-07-08 | — | — | US | disclosed |
| EP-2641907-A1 | Preparation of modulators of 5-HT receptors | AbbVie Inc. (US) | 2013-09-25 | — | — | EP | disclosed |
| US-20130231353-A1 | PYRIDO- AND PYRIMIDOPYRIMIDINE DERIVATIVES AS ANTI-PROFILERATIVE AGENTS | JANSSEN PHARMACEUTICA N.V. (BE) | 2013-09-05 | — | — | US | disclosed |
| CN-103275133-A | Synthetic method of beta-D-oligomannuronate or glucoside | OCEAN UNIV CHINA | 2013-09-04 | — | — | CN | disclosed |
| CN-103275169-A | Furostanol saponins and synthesis method thereof | OCEAN UNIV CHINA | 2013-09-04 | — | — | CN | disclosed |
| CN-103265608-A | Solanidine type glycoalkaloid and convergent synthesis method thereof | OCEAN UNIV CHINA | 2013-08-28 | — | — | CN | disclosed |
| US-20130178505-A1 | Compounds for the Inhibition of Cellular Proliferation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2013-07-11 | — | — | US | disclosed |
| US-20130178505-A1 | Compounds for the Inhibition of Cellular Proliferation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2013-07-11 | — | — | US | disclosed |
| US-20130178624-A1 | QUINAZOLINE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 2013-07-11 | — | — | US | disclosed |
| EP-2485728-B1 | WNT PATHWAY ANTAGONISTS | SIENA BIOTECH SPA (IT) | 2013-07-10 | — | — | EP | disclosed |
| EP-2485728-B1 | WNT PATHWAY ANTAGONISTS | SIENA BIOTECH SPA (IT) | 2013-07-10 | — | — | EP | disclosed |
| CN-103193858-A | Synthetic method of spirosolane glycoalkaloids | OCEAN UNIV CHINA | 2013-07-10 | — | — | CN | disclosed |
| EP-2585459-A1 | ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | Chiesi Farmaceutici S.p.A. (IT) | 2013-05-01 | — | — | EP | disclosed |
| EP-2585453-A2 | COMPOUNDS FOR THE INHIBITION OF CELLULAR PROLIFERATION | President and Fellows of Harvard College (US) | 2013-05-01 | — | — | EP | disclosed |
| EP-2432783-B1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBOTT LAB (US) | 2013-05-01 | — | — | EP | disclosed |
| EP-2576700-A1 | PIGMENT DISPERSIONS, RELATED COATING COMPOSITIONS AND COATED SUBSTRATES | PPG Industries Ohio, Inc. (US) | 2013-04-10 | — | — | EP | disclosed |
| EP-2571353-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | AbbVie Inc. (US) | 2013-03-27 | — | — | EP | disclosed |
| US-8394786-B2 | Quinazoline derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 2013-03-12 | — | — | US | disclosed |
| US-8394955-B2 | 2,4 (4,6) pyrimidine derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 2013-03-12 | — | — | US | disclosed |
| EP-2485728-A1 | WNT PATHWAY ANTAGONISTS | Siena Biotech S.p.a. (IT) | 2012-08-15 | — | — | EP | disclosed |
| US-20120196851-A1 | WNT PATHWAY ANTAGONISTS | SIENA BIOTECH S.P.A. (IT) | 2012-08-02 | — | — | US | disclosed |
| US-20120196851-A1 | WNT PATHWAY ANTAGONISTS | SIENA BIOTECH S.P.A. (IT) | 2012-08-02 | — | — | US | disclosed |
| US-20120196851-A1 | WNT PATHWAY ANTAGONISTS | SIENA BIOTECH S.P.A. (IT) | 2012-08-02 | — | — | US | disclosed |
| WO-2012078956-A1 | POLYMERIC SUBSTRATES HAVING A THIN METAL FILM AND FINGERPRINT RESISTANT CLEAR COATING DEPOSITED THEREON AND RELATED METHODS | PPG INDUSTRIES OHIO, INC. (US) | 2012-06-14 | — | — | WO | disclosed |
| US-20120148846-A1 | COLOR PLUS CLEAR COATING SYSTEMS EXHIBITING DESIRABLE APPEARANCE AND FINGERPRINT RESISTANCE PROPERTIES AND RELATED METHODS | PPG INDUSTRIES OHIO, INC. (US) | 2012-06-14 | — | — | US | disclosed |
| WO-2012078953-A1 | COLOR PLUS CLEAR COATING SYSTEMS EXHIBITING DESIRABLE APPEARANCE AND FINGERPRINT RESISTANCE PROPERTIES AND RELATED METHODS | PPG INDUSTRIES OHIO, INC. (US) | 2012-06-14 | — | — | WO | disclosed |
| US-8148388-B2 | 2,4 (4,6) pyrimidine derivatives | JANSSEN PHARMACEUTICA, N.V. (BE) | 2012-04-03 | — | — | US | disclosed |
| EP-2432783-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | Abbott Laboratories (US) | 2012-03-28 | — | — | EP | disclosed |
| US-20120065395-A1 | 2,4 (4,6) PYRIMIDINE DERIVATIVES | FREYNE EDDY JEAN EDGARD (BE) | 2012-03-15 | — | — | US | disclosed |
| WO-2012006068-A2 | COMPOUNDS FOR THE INHIBITION OF CELLULAR PROLIFERATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-01-12 | — | — | WO | disclosed |
| WO-2011161018-A1 | ALKALOID AMINOESTER DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF | CHIESI FARMACEUTICI S.P.A. (IT) | 2011-12-29 | — | — | WO | disclosed |
| WO-2011146089-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBOTT LABORATORIES (US) | 2011-11-24 | — | — | WO | disclosed |
| WO-2011134067-A1 | NOVEL AMINO ACID MOLECULE AND USES THEREOF | 6570763 CANADA INC. (CA) | 2011-11-03 | — | — | WO | disclosed |
| EP-2375899-A1 | PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF | Array Biopharma, Inc. (US) | 2011-10-19 | — | — | EP | disclosed |
| US-20110118473-A1 | PROCESS FOR CONVERTING 9-DIHYDRO-13ACETYLBACCATIN III PACLITAXEL AND DOCETAXEL | 6570763 CANADA INC. (CA) | 2011-05-19 | — | — | US | disclosed |
| US-20110118231-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBOTT LABORATORIES (US) | 2011-05-19 | — | — | US | disclosed |
| CN-101468964-B | Processes for producing indole compound | NISSAN CHEMICAL IND LTD | 2011-05-11 | — | — | CN | disclosed |
| CN-101468964-B | Processes for producing indole compound | NISSAN CHEMICAL IND LTD | 2011-05-11 | — | — | CN | disclosed |
| WO-2011042145-A1 | WNT PATHWAY ANTAGONISTS | SIENA BIOTECH S.P.A. (IT) | 2011-04-14 | — | — | WO | disclosed |
| WO-2011042145-A1 | WNT PATHWAY ANTAGONISTS | SIENA BIOTECH S.P.A. (IT) | 2011-04-14 | — | — | WO | disclosed |
| US-7847111-B2 | Semi-synthetic route for the preparation of paclitaxel, docetaxel, and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III | CANADA INC. (CA) | 2010-12-07 | — | — | US | disclosed |
| WO-2010135560-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBOTT LABORATORIES (US) | 2010-11-25 | — | — | WO | disclosed |
| US-20100298340-A1 | Thiazol-Guanidine Derivatives Useful As A (Beta)-Related Pathologies | ASTRAZENECA AB (SE) | 2010-11-25 | — | — | US | disclosed |
| US-20100298340-A1 | Thiazol-Guanidine Derivatives Useful As A (Beta)-Related Pathologies | ASTRAZENECA AB (SE) | 2010-11-25 | — | — | US | disclosed |
| US-20100298340-A1 | Thiazol-Guanidine Derivatives Useful As A (Beta)-Related Pathologies | ASTRAZENECA AB (SE) | 2010-11-25 | — | — | US | disclosed |
| US-20100298292-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBOTT LABORATORIES (US) | 2010-11-25 | — | — | US | disclosed |
| US-7816397-B2 | Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes | MERCK PATENT GMBH (DE) | 2010-10-19 | — | — | US | disclosed |
| US-7799772-B2 | tyrosine kinase inhibitors such as 7H,19H-4,6-ethanediylidenepyrimido[4,5-b][13,1,4,6]benzoxatriazacyclopentadecine, 17-chloro-8,9,10,11,12,13-hexahydro, used for treating hyper proliferative disorders such as atherosclerosis, restenosis and cancer | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-09-21 | — | — | US | disclosed |
| US-20100197938-A1 | Process for producing indole compoud | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-08-05 | — | — | US | disclosed |
| US-20100197938-A1 | Process for producing indole compoud | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-08-05 | — | — | US | disclosed |
| WO-2010080864-A1 | PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF | ARRAY BIOPHARMA INC. (US) | 2010-07-15 | — | — | WO | disclosed |
| US-20100173913-A1 | PYRIDO-AND PYRIMIDOPYRIMIDINE DERIVATIVES AS ANTI-PROLIFERATIVE AGENTS | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-07-08 | — | — | US | disclosed |
| US-20100160310-A1 | 2,4 (4,6) PYRIMIDINE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-06-24 | — | — | US | disclosed |
| EP-2183234-A1 | PROCESS FOR CONVERTING 9-DIHYDRO-13-ACETYLBACCATIN III INTO DOCETAXEL OR PACLITAXEL | 6570763 Canada Inc. (CA) | 2010-05-12 | — | — | EP | disclosed |
| US-20100105668-A1 | Quinazoline derivatives | FREYNE EDDY JEAN EDGARD | 2010-04-29 | — | — | US | disclosed |
| US-7648975-B2 | Macrocyclic quinazoline derivatives as antiproliferative agents | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-01-19 | — | — | US | disclosed |
| US-7648975-B2 | Macrocyclic quinazoline derivatives as antiproliferative agents | JANSSEN PHARMACEUTICA N.V. (BE) | 2010-01-19 | — | — | US | disclosed |
| CN-100577659-C | Processes for producing indole compound | NISSAN CHEMICAL IND LTD | 2010-01-06 | — | — | CN | disclosed |
| CN-100577659-C | Processes for producing indole compound | NISSAN CHEMICAL IND LTD | 2010-01-06 | — | — | CN | disclosed |
| EP-2114958-A1 | INHIBITORS OF SERINE PROTEASES FOR THE TREATMENT OF HCV INFECTIONS | Vertex Pharmceuticals Incorporated (US) | 2009-11-11 | — | — | EP | disclosed |
| EP-1829872-A4 | PROCESSES FOR PRODUCTION OF INDOLE COMPOUNDS | NISSAN CHEMICAL IND LTD (JP) | 2009-08-19 | — | — | EP | disclosed |
| WO-2009090548-A2 | 3-AZABICYCLO [3.1.0] HEXANE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS | GLENMARK PHARMACEUTICALS, S.A. (US) | 2009-07-23 | — | — | WO | disclosed |
| CN-101468964-A | Processes for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2009-07-01 | — | — | CN | disclosed |
| CN-101468964-A | Processes for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2009-07-01 | — | — | CN | disclosed |
| CN-101466692-A | Thiazol-guanidine derivatives useful as a (beta) - related pathologies | ASTRAZENECA AB (SE) | 2009-06-24 | — | — | CN | disclosed |
| US-7550410-B2 | Method and apparatus for combinatorial chemistry | FOOTE ROBERT S | 2009-06-23 | — | — | US | disclosed |
| EP-2029563-A1 | SEMI-SYNTHETIC ROUTE FOR THE PREPARATION OF PACLITAXEL, DOCETAXEL AND 10-DEACETYLBACCATIN III FROM 9-DIHYDRO-13-ACETYLBACCATIN III | 6570763 Canada Inc. (CA) | 2009-03-04 | — | — | EP | disclosed |
| WO-2009023967-A1 | PROCESS FOR CONVERTING 9-DIHYDRO-13-ACETYLBACCATIN III INTO DOCETAXEL OR PACLITAXEL | 6570763 CANADA INC. (CA) | 2009-02-26 | — | — | WO | disclosed |
| EP-2010508-A1 | THIAZOL-GUANIDINE DERIVATIVES USEFUL AS A (BETA)- RELATED PATHOLOGIES | AstraZeneca AB (SE) | 2009-01-07 | — | — | EP | disclosed |
| EP-2004716-A2 | METHOD OF MAKING URETHANE BASED FLUORINATED MONOMERS | 3M Innovative Properties Company (US) | 2008-12-24 | — | — | EP | disclosed |
| WO-2008106139-A1 | INHIBITORS OF SERINE PROTEASES FOR THE TREATMENT OF HCV INFECTIONS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-09-04 | — | — | WO | disclosed |
| EP-1928845-A2 | AMINODIAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS | Array Biopharma, Inc. (US) | 2008-06-11 | — | — | EP | disclosed |
| EP-1917269-A2 | INHIBITORS OF SERINE PROTEASES | Vertex Pharmaceuticals Incorporated (US) | 2008-05-07 | — | — | EP | disclosed |
| US-20080045483-A1 | Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes | MERCK PATENT GMBH (DE) | 2008-02-21 | — | — | US | disclosed |
| WO-2007143839-A1 | SEMI-SYNTHETIC ROUTE FOR THE PREPARATION OF PACLITAXEL, DOCETAXEL AND 10-DEACETYLBACCATIN III FROM 9-DIHYDRO-13-ACETYLBACCATIN III | 6570763 CANADA INC. (CA) | 2007-12-21 | — | — | WO | disclosed |
| US-20070293687-A1 | SEMI-SYNTHETIC ROUTE FOR THE PREPARATION OF PACLITAXEL, DOCETAXEL, AND 10-DEACETYLBACCATIN III FROM 9-DIHYDRO-13-ACETYLBACCATIN III | 6570763 CANADA INC. (CA) | 2007-12-20 | — | — | US | disclosed |
| WO-2007124263-A2 | METHOD OF MAKING URETHANE BASED FLUORINATED MONOMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2007-11-01 | — | — | WO | disclosed |
| WO-2007120096-A1 | THIAZOL-GUANIDINE DERIVATIVES USEFUL AS A (BETA)- RELATED PATHOLOGIES | ASTRAZENECA AB (SE) | 2007-10-25 | — | — | WO | disclosed |
| WO-2007120096-A1 | THIAZOL-GUANIDINE DERIVATIVES USEFUL AS A (BETA)- RELATED PATHOLOGIES | ASTRAZENECA AB (SE) | 2007-10-25 | — | — | WO | disclosed |
| US-20070244289-A1 | METHOD OF MAKING URETHANE BASED FLUORINATED MONOMERS | 3M INNOVATIVE PROPERTIES COMPANY | 2007-10-18 | — | — | US | disclosed |
| EP-1829872-A1 | PROCESSES FOR PRODUCTION OF INDOLE COMPOUNDS | Nissan Chemical Industries, Ltd. (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-20070087367-A1 | METHOD AND APPARATUS FOR COMBINATORIAL CHEMISTRY | FOOTE ROBERT S | 2007-04-19 | — | — | US | disclosed |
| WO-2007040840-A2 | AMINODIAZEPINES AS TOLL-LIKE RECEPTOR MODULATORS | ARRAY BIOPHARMA INC. (US) | 2007-04-12 | — | — | WO | disclosed |
| US-20070083053-A1 | Process for producing indole compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-04-12 | — | — | US | disclosed |
| US-20070083053-A1 | Process for producing indole compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2007-04-12 | — | — | US | disclosed |
| US-20070078132-A1 | tyrosine kinase inhibitors such as 7H,19H-4,6-ethanediylidenepyrimido[4,5-b][13,1,4,6]benzoxatriazacyclopentadecine, 17-chloro-8,9,10,11,12,13-hexahydro, used for treating hyper proliferative disorders such as atherosclerosis, restenosis and cancer | JANSSEN-CILAG (FR) | 2007-04-05 | — | — | US | disclosed |
| EP-1761486-A1 | PHENYLCARBOXYLIC ACID DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF DIABETES | Merck Patent GmbH (DE) | 2007-03-14 | — | — | EP | disclosed |
| WO-2007025307-A2 | INHIBITORS OF SERINE PROTEASES | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2007-03-01 | — | — | WO | disclosed |
| US-7179591-B2 | Method and apparatus for combinatorial chemistry | Foote, Robert S. (US) | 2007-02-20 | — | — | US | disclosed |
| CN-1896075-A | Processes for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2007-01-17 | — | — | CN | disclosed |
| CN-1896075-A | Processes for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2007-01-17 | — | — | CN | disclosed |
| CN-1286810-C | 2-acyl indol derivatives and their use as anti-tumour agents | BAKST HEALTH AG (CH) | 2006-11-29 | — | — | CN | disclosed |
| CN-1286832-C | Process for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2006-11-29 | — | — | CN | disclosed |
| CN-1286832-C | Process for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2006-11-29 | — | — | CN | disclosed |
| JP-2006176500-A | PROCESS FOR PRODUCING INDOLE COMPOUND | NISSAN CHEM IND LTD | 2006-07-06 | — | — | JP | disclosed |
| WO-2006057354-A1 | PROCESSES FOR PRODUCTION OF INDOLE COMPOUNDS | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2006-06-01 | — | — | WO | disclosed |
| WO-2006000288-A1 | PHENYLCARBOXYLIC ACID DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF DIABETES | MERCK PATENT GMBH (DE) | 2006-01-05 | — | — | WO | disclosed |
| CN-1646522-A | Process for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2005-07-27 | — | — | CN | disclosed |
| CN-1646522-A | Process for producing indole compound | NISSAN CHEMICAL IND LTD (JP) | 2005-07-27 | — | — | CN | disclosed |
| EP-1048658-B1 | ALICYCLIC ACYLATED HETEROCYCLIC DERIVATIVES | SANKYO CO (JP) | 2005-06-15 | — | — | EP | disclosed |
| EP-1159285-B1 | METHODS AND COMPOSITIONS FOR ECONOMICALLY SYNTHESIZING AND ASSEMBLING LONG DNA SEQUENCES | METRIGEN INC (US) | 2005-05-25 | — | — | EP | disclosed |
| JP-2005035991-A | METHOD FOR PRODUCING INDOLE COMPOUND | NISSAN CHEM IND LTD | 2005-02-10 | — | — | JP | disclosed |
| US-20050009092-A1 | Method and apparatus for conducting an array of chemical reactions on a support surface | BRENNAN THOMAS M (US) | 2005-01-13 | — | — | US | disclosed |
| WO-2005000812-A1 | PROCESS FOR PRODUCING INDOLE COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2005-01-06 | — | — | WO | disclosed |
| EP-0831094-B1 | FUSED POLYCYCLIC HETEROCYCLE DERIVATIVES | EISAI CO LTD (JP) | 2004-12-08 | — | — | EP | disclosed |
| EP-1076677-B1 | CERAMER COMPOSITION HAVING ABRASION AND STAIN RESISTANT CHARACTERISTICS | 3M INNOVATIVE PROPERTIES CO (US) | 2004-10-27 | — | — | EP | disclosed |
| CN-1142932-C | N,N-dimethyl-1-t-butoxycarbonyl-4-phenylpiperidine-4-carboxamide | ������������ʽ���� | 2004-03-24 | — | — | CN | disclosed |
| JP-2004083559-A | PRODUCTION PROCESS FOR INDOLE COMPOUND | NISSAN CHEM IND LTD | 2004-03-18 | — | — | JP | disclosed |
| US-20030232382-A1 | Method and apparatus for performing large numbers of reactions using array assembly | BRENNAN THOMAS M (US) | 2003-12-18 | — | — | US | disclosed |
| US-6632641-B1 | Filling wells in solid supports with reactants; releasing polynucleotides into solution in wells; amplification | METRIGEN, INC. | 2003-10-14 | — | — | US | disclosed |
| WO-2003082860-A1 | PROCESSES FOR PRODUCING INDOLE COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2003-10-09 | — | — | WO | disclosed |
| US-20030186226-A1 | Methods and compositions for economically synthesizing and assembling long DNA sequences | MOLINARI, ROBERT J., PH.D. AS COLLATERAL AGENT | 2003-10-02 | — | — | US | disclosed |
| CN-1121398-C | Alicyclic acylated heterocyclic derivatives | SANKYO CO (JP) | 2003-09-17 | — | — | CN | disclosed |
| CN-1431997-A | 2-acylindole derivatives and their use as antitumor agents | BAKST HEALTH AG (CH) | 2003-07-23 | — | — | CN | disclosed |
| US-6589726-B1 | Reacting surface with reagent to form a hydrophilic surface; coating with a photoresist substance; exposing to light and developing to form a pattern; reacting with a second reagent to form hydrophobic sites and removing photoresist coat; | METRIGEN, INC. | 2003-07-08 | — | — | US | disclosed |
| US-20030068643-A1 | Methods and compositions for economically synthesizing and assembling long DNA sequences | BRENNAN THOMAS M (US) | 2003-04-10 | — | — | US | disclosed |
| US-6448247-B1 | TACHYKININ RECEPTOR ANTAGONIST; ESPECIALLY TO THE RECEPTORS FOR SUBSTANCE P (WHICH RECEPTORS ARE GENERALLY REFERRED TO AS ?NEUROKININ 1 RECEPTORS?) | SANKYO COMPANY, LIMITED (JP) | 2002-09-10 | — | — | US | disclosed |
| EP-1235932-A2 | METHOD AND APPARATUS FOR PERFORMING LARGE NUMBERS OF REACTIONS USING ARRAY ASSEMBLY | Protogene Laboratories, Inc. (US) | 2002-09-04 | — | — | EP | disclosed |
| EP-0869126-B1 | Dithiolan derivatives, their preparation and their therapeutic effect | SANKYO CO (JP) | 2002-07-31 | — | — | EP | disclosed |
| US-6358601-B1 | POLYMER MATRIX, SURFACE TREATED INORGANIC OXIDE IN MATRIX AND ANTISTATIC AGENT WITH NONIONIC SURFACTANT | 3M INNOVATIVE PROPERTIES COMPANY | 2002-03-19 | — | — | US | disclosed |
| WO-2002016023-A2 | METHOD AND APPARATUS FOR IN SITU SYNTHESIS ON A SOLID SUPPORT | PROTOGENE LABORATORIES, INC. (US) | 2002-02-28 | — | — | WO | disclosed |
| EP-0776893-B1 | Azaheterocyclic compounds having tachykinin receptor antagonist activity; Nk1 and NK2 | SANKYO CO (JP) | 2002-02-27 | — | — | EP | disclosed |
| EP-1163298-A1 | CERAMER COMPOSITION AND COMPOSITE COMPRISING FREE RADICALLY CURABLE FLUOROCHEMICAL COMPONENT | 3M Innovative Properties Company (US) | 2001-12-19 | — | — | EP | disclosed |
| EP-1159285-A1 | METHODS AND COMPOSITIONS FOR ECONOMICALLY SYNTHESIZING AND ASSEMBLING LONG DNA SEQUENCES | Protogene Laboratories, Inc. (US) | 2001-12-05 | — | — | EP | disclosed |
| US-6313164-B1 | TO ENHANCE THE ACTIVITY OF GLUTATHIONE RECLUCTASE; FOR THERAPY AND PROPHYLAXIS OF CARTARACTS | SANKYO COMPANY, LIMITED (JP) | 2001-11-06 | — | — | US | disclosed |
| US-20010029028-A1 | Method and apparatus for combinatorial chemistry | FOOTE, ROBERT S. | 2001-10-11 | — | — | US | disclosed |
| EP-1140828-A1 | 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVES AS OPIATE RECEPTORS LIGANDS | Pfizer Limited (GB) | 2001-10-10 | — | — | EP | disclosed |
| US-6288059-B1 | ANTIASTHMATIC, ANTIALLERGEN AGENTS; URINARY INCONTINENCE; NATURAL KILLER CELL RECEPTOR AND TACHYKININ ANTAGONISTS | SANKYO COMPANY, LIMITED (JP) | 2001-09-11 | — | — | US | disclosed |
| CN-1067686-C | Fused polycyclic heterocycle derivatives | EISAI CO LTD (JP) | 2001-06-27 | — | — | CN | disclosed |
| US-6238798-B1 | CURABLE CERAMER COMPOSITION PROVIDING HARDNESS, ABRASION RESISTANCE, STAIN, OIL AND/OR WATER REPELLENCY; OPTICS | 3M INNOVATIVE PROPERTIES COMPANY | 2001-05-29 | — | — | US | disclosed |
| WO-2001027327-A2 | METHOD AND APPARATUS FOR PERFORMING LARGE NUMBERS OF REACTIONS USING ARRAY ASSEMBLY | PROTOGENE LABORATORIES, INC. (US) | 2001-04-19 | — | — | WO | disclosed |
| EP-1087963-A1 | INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 | Chiron Corporation (US) | 2001-04-04 | — | — | EP | disclosed |
| US-6210894-B1 | Method and apparatus for conducting an array of chemical reactions on a support surface | PROTOGENE LABORATORIES, INC. | 2001-04-03 | — | — | US | disclosed |
| WO-2001018082-A1 | RETROREFLECTIVE ARTICLES INCLUDING A CURED CERAMER COMPOSITE COATING | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-03-15 | — | — | WO | disclosed |
| EP-1082497-A1 | RETROREFLECTIVE ARTICLES INCLUDING A CURED CERAMER COMPOSITE COATING HAVING ABRASION AND STAIN RESISTANT CHARACTERISTICS | 3M Innovative Properties Company (US) | 2001-03-14 | — | — | EP | disclosed |
| EP-1070710-A2 | Dithiolan derivatives, their preparation and their therapeutic effect | Sankyo Company Limited (JP) | 2001-01-24 | — | — | EP | disclosed |
| US-6159967-A | Heterocyclic compounds having tachykinin receptor antagonist activity their preparation and their use | SANKYO COMPANY, LIMITED (JP) | 2000-12-12 | — | — | US | disclosed |
| WO-2000066259-A1 | METHOD AND APPARATUS FOR COMBINATORIAL CHEMISTRY | UT-BATTELLE, LLC (US) | 2000-11-09 | — | — | WO | disclosed |
| EP-1048658-A1 | ALICYCLIC ACYLATED HETEROCYCLIC DERIVATIVES | Sankyo Company Limited (JP) | 2000-11-02 | — | — | EP | disclosed |
| WO-2000053617-A1 | METHODS AND COMPOSITIONS FOR ECONOMICALLY SYNTHESIZING AND ASSEMBLING LONG DNA SEQUENCES | PROTOGENE LABORATORIES, INC. (US) | 2000-09-14 | — | — | WO | disclosed |
| WO-2000050517-A1 | CERAMER COMPOSITION AND COMPOSITE COMPRISING FREE RADICALLY CURABLE FLUOROCHEMICAL COMPONENT | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2000-08-31 | — | — | WO | disclosed |
| WO-2000039089-A1 | 3-AZABICYCLO[3.1.0.] HEXANE DERIVATIVES AS OPIATE RECEPTORS LIGANDS | PFIZER LIMITED (GB) | 2000-07-06 | — | — | WO | disclosed |
| US-6013663-A | CATARACT THERAPY OR PREVENTION | SANKYO COMPANY, LIMITED (JP) | 2000-01-11 | — | — | US | disclosed |
| WO-1999065897-A1 | INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 | CHIRON CORPORATION (US) | 1999-12-23 | — | — | WO | disclosed |
| US-5985551-A | Method and apparatus for conducting an array of chemical reactions on a support surface | PROTOGENE LABORATORIES, INC. (US) | 1999-11-16 | — | — | US | disclosed |
| WO-1999057375-A1 | RETROREFLECTIVE ARTICLES INCLUDING A CURED CERAMER COMPOSITE COATING HAVING ABRASION AND STAIN RESISTANT CHARACTERISTICS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 1999-11-11 | — | — | WO | disclosed |
| US-5952335-A | ANTITUMOR AGENTS | EISAI CO., LTD. (JP) | 1999-09-14 | — | — | US | disclosed |
| CN-1208035-A | Dithiolan derivatives, their preparation and their therapeutic effect | SANKYO CO (JP) | 1999-02-17 | — | — | CN | disclosed |
| EP-0869126-A1 | Dithiolan derivatives, their preparation and their therapeutic effect | Sankyo Company Limited (JP) | 1998-10-07 | — | — | EP | disclosed |
| EP-0489547-B1 | A process for the preparation of a 3-alkylated indole, intermediates, and a process for the preparation of a derivative thereof | ZENECA LTD (GB) | 1998-07-29 | — | — | EP | disclosed |
| CN-1185781-A | Fused Polycyclic Heterocyclic Derivatives | EISAI CO LTD (JP) | 1998-06-24 | — | — | CN | disclosed |
| EP-0831094-A1 | FUSED POLYCYCLIC HETEROCYCLE DERIVATIVES | Eisai Co., Ltd. (JP) | 1998-03-25 | — | — | EP | disclosed |
| CN-1157286-A | N,N-dimethyl-1-t-butoxycarbonyl-4-phenylpiperidine-4-carboxamide | SANKYO CO (JP) | 1997-08-20 | — | — | CN | disclosed |
| EP-0703825-B1 | METHOD AND APPARATUS FOR CONDUCTING AN ARRAY OF CHEMICAL REACTIONS ON A SUPPORT SURFACE | PROTOGENE LAB INC (US) | 1997-07-30 | — | — | EP | disclosed |
| EP-0776893-A1 | Azaheterocyclic compounds having tachykinin receptor antagonist activity; Nk1 and NK2 | SANKYO COMPANY LIMITED (JP) | 1997-06-04 | — | — | EP | disclosed |
| EP-0703825-A1 | METHOD AND APPARATUS FOR CONDUCTING AN ARRAY OF CHEMICAL REACTIONS ON A SUPPORT SURFACE | PROTOGENE LAB INC (US) | 1996-04-03 | — | — | EP | disclosed |
| CN-1030739-C | Method for selectively coating metal surface, method for forming circuit pattern from metal surface and photosensitive emulsion used therefor | GRACE W R & CO (US) | 1996-01-17 | — | — | CN | disclosed |
| US-5474796-A | Immobilization | PROTOGENE LABORATORIES, INC. (US) | 1995-12-12 | — | — | US | disclosed |
| WO-1994027719-A1 | METHOD AND APPARATUS FOR CONDUCTING AN ARRAY OF CHEMICAL REACTIONS ON A SUPPORT SURFACE | PROTOGENE LABORATORIES, INC. (US) | 1994-12-08 | — | — | WO | disclosed |
| US-5280125-A | Chemical process for the preparation of 3-alkylated indole | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1994-01-18 | — | — | US | disclosed |
| US-5280125-A | Chemical process for the preparation of 3-alkylated indole | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1994-01-18 | — | — | US | disclosed |
| EP-0512074-A4 | MOLECULES WITH ANTIBODY COMBINING SITES THAT CATALYSE HYDROLYSIS REACTIONS | — | 1993-07-14 | — | — | EP | disclosed |
| US-5164499-A | Nitroaryl carbonyl compounds, nitrodihydroaryl carbonyl intermediates thereto, and processes | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-11-17 | — | — | US | disclosed |
| EP-0512074-A1 | MOLECULES WITH ANTIBODY COMBINING SITES THAT CATALYSE HYDROLYSIS REACTIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1992-11-11 | — | — | EP | disclosed |
| JP-H04266870-A | CHEMICAL PRODUCTION | IMPERIAL CHEM IND PLC <ICI> | 1992-09-22 | — | — | JP | disclosed |
| EP-0489547-A1 | A process for the preparation of a 3-alkylated indole, intermediates, and a process for the preparation of a derivative thereof | ZENECA LIMITED (GB) | 1992-06-10 | — | — | EP | disclosed |
| EP-0489547-A1 | A process for the preparation of a 3-alkylated indole, intermediates, and a process for the preparation of a derivative thereof | ZENECA LIMITED (GB) | 1992-06-10 | — | — | EP | disclosed |
| CN-1054836-A | Automatic deposition emulsion and the method for the metal surface being carried out selective protection with this emulsion | GRACE W R & CO (US) | 1991-09-25 | — | — | CN | disclosed |
| WO-1991011512-A1 | MOLECULES WITH ANTIBODY COMBINING SITES THAT CATALYSE HYDROLYSIS REACTIONS | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1991-08-08 | — | — | WO | disclosed |
| US-4912220-A | Mixing a nitroaryl compound with an unsaturated silane under anhydrous conditions; adding a fluoride compound and an electrophilic compound | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-03-27 | — | — | US | disclosed |
| US-4810282-A | 3-ORTHO-(ISOXAZOLYL,ISOTHIAZOLYL, PYRAZOLYL,THIADIAZOLYL, OXADIAZOLYL AND TRIAZOLYL BENZENESULFONUREYLENE-1,2,4-TRIAZOLES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-03-07 | — | — | US | disclosed |
| US-4743690-A | NITROARYL COMPOUND, SILANE, FLUORO ONIUM COMPOUND, BROMIDE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-05-10 | — | — | US | disclosed |
| EP-0083975-B1 | HERBICIDAL SULFONAMIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-11-19 | — | — | EP | disclosed |
| US-4695311-A | Herbicidal sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-09-22 | — | — | US | disclosed |
| US-4659862-A | Process of preparing nitrodihydroaryl carbonyl compounds | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-04-21 | — | — | US | disclosed |
| US-4606755-A | Herbicidal sulfonamides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-08-19 | — | — | US | disclosed |
| US-4536391-A | REACTING A PLASMIN HEAVY CHAIN WITH UROKINASE IN THE PRESENCE OF A COUPLING AGENT | OTSUKA PHARMACEUTICAL CO. (JP) | 1985-08-20 | — | — | US | disclosed |
| US-4511392-A | N--/PYRIMIDIN-2-YLAMINOCARBENYL/-HETERO-SUBSTITUETED BENZENSESULFO | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-04-16 | — | — | US | disclosed |
| US-4454337-A | Semicarbazide intermediates for preparing 4-substituted indoles | SMITHKLINE BECKMAN CORPORATION (US) | 1984-06-12 | — | — | US | disclosed |
| EP-0109653-A2 | Process for preparing urokinase complex | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1984-05-30 | — | — | EP | disclosed |
| EP-0083975-A2 | Herbicidal sulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1983-07-20 | — | — | EP | disclosed |
| US-4394514-A | Processes for preparing 4-substituted indoles | SMITHKLINE BECKMAN CORPORATION (US) | 1983-07-19 | — | — | US | disclosed |
| US-4333930-A | TREATMENT OF CENTRAL NERVOUS DISORDERS, ANALGESICS, ANTIDEPRESSANTS | LABORATOIRES SARGET (FR) | 1982-06-08 | — | — | US | disclosed |
| US-4127581-A | Method for the preparation of 3-phenyl-5-substituted-4(1H)-pyridones | ELI LILLY AND COMPANY (US) | 1978-11-28 | — | — | US | disclosed |
| US-3979410-A | Intermediate α-acyl-β-dialkylamino-2-nitrostyrenes | HOFFMANN-LA ROCHE INC. (US) | 1976-09-07 | — | — | US | disclosed |
| US-3979410-A | Intermediate α-acyl-β-dialkylamino-2-nitrostyrenes | HOFFMANN-LA ROCHE INC. (US) | 1976-09-07 | — | — | US | disclosed |
| US-3931225-A | Process for preparing o-nitrobenzylketones | HOFFMANN-LA ROCHE INC. (US) | 1976-01-06 | — | — | US | disclosed |
| US-3931225-A | Process for preparing o-nitrobenzylketones | HOFFMANN-LA ROCHE INC. (US) | 1976-01-06 | — | — | US | disclosed |
| US-3931225-A | Process for preparing o-nitrobenzylketones | HOFFMANN-LA ROCHE INC. (US) | 1976-01-06 | — | — | US | disclosed |
| US-3931225-A | Process for preparing o-nitrobenzylketones | HOFFMANN-LA ROCHE INC. (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (25 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130178624-A1 | QUINAZOLINE DERIVATIVES | NR1H2, NR1H3, NR3C2 | ALDH1A1 2807/4885TSHR 496/4885HPGD 344/4885 |
| US-20070293687-A1 | SEMI-SYNTHETIC ROUTE FOR THE PREPARATION OF PACLITAXEL, DOCETAXEL, AND 10-DEACETYLBACCATIN III FROM 9-DIHYDRO-13-ACETYLBACCATIN III | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, KAT5, KYAT3 | ALDH1A1 3256/4885TSHR 4282/4885HPGD 1598/4885 |
| US-20070078132-A1 | tyrosine kinase inhibitors such as 7H,19H-4,6-ethanediylidenepyrimido[4,5-b][13,1,4,6]benzoxatriazacyclopentadecine, 17-chloro-8,9,10,11,12,13-hexahydro, used for treating hyper proliferative disorders such as atherosclerosis, restenosis and cancer | NR1H3, NR1H2, ERBB2 | ALDH1A1 3804/4885TSHR 1124/4885HPGD 589/4885 |
| US-20220378762-A1 | 4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES | EGFR, ERBB2, ERBB4 | ALDH1A1 1255/4885TSHR 2270/4885HPGD 235/4885 |
| US-20160096851-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | HTR3A, HTR5A, HTR3C | ALDH1A1 971/4885TSHR 136/4885HPGD 504/4885 |
| US-20100298292-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | HTR3A, HTR5A, HTR3C | ALDH1A1 971/4885TSHR 136/4885HPGD 504/4885 |
| US-20130231353-A1 | PYRIDO- AND PYRIMIDOPYRIMIDINE DERIVATIVES AS ANTI-PROFILERATIVE AGENTS | NR4A1, CYP2J2, NR3C2 | ALDH1A1 1357/4885TSHR 1741/4885HPGD 273/4885 |
| US-12403135-B2 | 4H-pyrrolo[3,2-c]pyridin-4-one derivatives | EGFR, ERBB2, ERBB4 | ALDH1A1 1255/4885TSHR 2270/4885HPGD 235/4885 |
| US-20100298340-A1 | Thiazol-Guanidine Derivatives Useful As A (Beta)-Related Pathologies | GRN, MAPT, GUCY1B1 | ALDH1A1 1302/4885TSHR 2071/4885HPGD 1775/4885 |
| US-20110118231-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | HTR3A, HTR5A, HTR3C | ALDH1A1 971/4885TSHR 136/4885HPGD 504/4885 |
| US-20210179578-A1 | OX1 ANTAGONISTS | HCRTR1, HCRTR2, OXTR | ALDH1A1 974/4885TSHR 166/4885HPGD 2392/4885 |
| US-20100105668-A1 | Quinazoline derivatives | NR1H2, NR1H3, NR3C2 | ALDH1A1 2784/4885TSHR 433/4885HPGD 350/4885 |
| US-20180346484-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | HTR3A, HTR5A, HTR3C | ALDH1A1 971/4885TSHR 136/4885HPGD 504/4885 |
| US-20120196851-A1 | WNT PATHWAY ANTAGONISTS | WNT1, WNT3A, CTNNB1 | ALDH1A1 1797/4885TSHR 4195/4885HPGD 1628/4885 |
| US-20120065395-A1 | 2,4 (4,6) PYRIMIDINE DERIVATIVES | NR0B1, NR1H3, NCOA3 | ALDH1A1 1457/4885TSHR 1119/4885HPGD 580/4885 |
| US-20160207938-A1 | QUINAZOLINE DERIVATIVES | NR1H2, NR1H3, NR3C2 | ALDH1A1 2932/4885TSHR 362/4885HPGD 638/4885 |
| US-11339157-B1 | 4H-pyrrolo[3,2-c]pyridin-4-one derivatives | CYP4B1, CYP2C19, CYP3A4 | ALDH1A1 387/4885TSHR 1659/4885HPGD 172/4885 |
| US-20080045483-A1 | Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes | SLC5A1, ALDH7A1, ASS1 | ALDH1A1 61/4885TSHR 3483/4885HPGD 389/4885 |
| US-20100197938-A1 | Process for producing indole compoud | IDO1, IDO2, NOS2 | ALDH1A1 2357/4885TSHR 1679/4885HPGD 143/4885 |
| US-20130178505-A1 | Compounds for the Inhibition of Cellular Proliferation | MKI67, EIF2AK2, CDK2 | ALDH1A1 3428/4885TSHR 4098/4885HPGD 2477/4885 |
| US-20100160310-A1 | 2,4 (4,6) PYRIMIDINE DERIVATIVES | NR1H3, NR1H2, NR0B1 | ALDH1A1 1741/4885TSHR 1075/4885HPGD 513/4885 |
| US-20070083053-A1 | Process for producing indole compound | IDO2, IDO1, TDO2 | ALDH1A1 2793/4885TSHR 1763/4885HPGD 352/4885 |
| US-20160340331-A1 | NOVEL COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT | HSP90AB1, HSP90AA1, HSP90AB2P | ALDH1A1 963/4885TSHR 4447/4885HPGD 1314/4885 |
| US-20110118473-A1 | PROCESS FOR CONVERTING 9-DIHYDRO-13ACETYLBACCATIN III PACLITAXEL AND DOCETAXEL | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, TUBB6, TUBB3 | ALDH1A1 813/4885TSHR 4458/4885HPGD 367/4885 |
| US-20100173913-A1 | PYRIDO-AND PYRIMIDOPYRIMIDINE DERIVATIVES AS ANTI-PROLIFERATIVE AGENTS | CYP2J2, NR4A1, ALOX15 | ALDH1A1 1541/4885TSHR 2961/4885HPGD 151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.